550 related articles for article (PubMed ID: 11916936)
1. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Festa A; D'Agostino R; Tracy RP; Haffner SM;
Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Festa A; Hanley AJ; Tracy RP; D'Agostino R; Haffner SM
Circulation; 2003 Oct; 108(15):1822-30. PubMed ID: 14517163
[TBL] [Abstract][Full Text] [Related]
3. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy RP; Haffner SM
Kidney Int; 2000 Oct; 58(4):1703-10. PubMed ID: 11012904
[TBL] [Abstract][Full Text] [Related]
5. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
Hanley AJ; D'Agostino R; Wagenknecht LE; Saad MF; Savage PJ; Bergman R; Haffner SM;
Diabetes; 2002 Apr; 51(4):1263-70. PubMed ID: 11916954
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Festa A; D'Agostino R; Mykkänen L; Tracy RP; Zaccaro DJ; Hales CN; Haffner SM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):562-8. PubMed ID: 10073958
[TBL] [Abstract][Full Text] [Related]
7. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
Haffner SM; D'Agostino R; Festa A; Bergman RN; Mykkänen L; Karter A; Saad MF; Wagenknecht LE
Diabetes Care; 2003 Oct; 26(10):2796-803. PubMed ID: 14514582
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.
Meigs JB; O'donnell CJ; Tofler GH; Benjamin EJ; Fox CS; Lipinska I; Nathan DM; Sullivan LM; D'Agostino RB; Wilson PW
Diabetes; 2006 Feb; 55(2):530-7. PubMed ID: 16443791
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
10. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
[TBL] [Abstract][Full Text] [Related]
11. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
[TBL] [Abstract][Full Text] [Related]
12. The relation of body fat mass and distribution to markers of chronic inflammation.
Festa A; D'Agostino R; Williams K; Karter AJ; Mayer-Davis EJ; Tracy RP; Haffner SM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1407-15. PubMed ID: 11673759
[TBL] [Abstract][Full Text] [Related]
13. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
14. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
15. The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).
Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Festa A; Goodarzi MO; Stefanovski D; Olson NC; Norris JM; Rewers MJ; Hanley AJ
Diabetologia; 2013 Jan; 56(1):112-20. PubMed ID: 23052060
[TBL] [Abstract][Full Text] [Related]
16. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
[TBL] [Abstract][Full Text] [Related]
17. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
18. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes.
Stefanov T; Temelkova-Kurktschiev T; Koehler C; Henkel E; Schaper F; Hanefeld M
Folia Med (Plovdiv); 2012; 54(2):32-9. PubMed ID: 23101283
[TBL] [Abstract][Full Text] [Related]
19. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
